Trademark: 97059027
Status Date
Wednesday, April 3, 2024
Filing Date
Monday, October 4, 2021
Published for Opposition
Tuesday, July 19, 2022
5 Pharmaceutical preparations for the treatment of cancerous and viral diseases; pharmaceutical preparations for use in the field of oncology for the treatment of cancerous diseases; medical diagnostic reagents
1 Chemicals used in the manufacture of pharmaceuticals; biomedical compounds, namely, recombinant and synthetic polypeptides for universal masking of proteins and providing half-life extension, and protease-cleavable linkers to enable unmasking
Apr 3, 2024
Statement Of Use Processing Complete
Mar 13, 2024
Use Amendment Filed
Apr 3, 2024
Sou Extension 3 Granted
Mar 13, 2024
Sou Extension 3 Filed
Apr 3, 2024
Case Assigned To Intent To Use Paralegal
Mar 13, 2024
Teas Statement Of Use Received
Mar 13, 2024
Sou Teas Extension Received
Sep 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 13, 2023
Sou Extension 2 Granted
Sep 13, 2023
Sou Extension 2 Filed
Sep 13, 2023
Sou Teas Extension Received
Mar 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 6, 2023
Sou Extension 1 Granted
Mar 6, 2023
Sou Extension 1 Filed
Mar 6, 2023
Sou Teas Extension Received
Sep 13, 2022
Noa E-Mailed - Sou Required From Applicant
Jul 19, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 19, 2022
Published For Opposition
Jun 29, 2022
Notification Of Notice Of Publication E-Mailed
Jun 10, 2022
Approved For Pub - Principal Register
Jun 10, 2022
Examiner's Amendment Entered
Jun 10, 2022
Notification Of Examiners Amendment E-Mailed
Jun 10, 2022
Examiners Amendment E-Mailed
Jun 10, 2022
Examiners Amendment -Written
Jun 2, 2022
Assigned To Examiner
Oct 29, 2021
New Application Office Supplied Data Entered
Oct 7, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
